4.3 Article

Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer

Related references

Note: Only part of the references are listed.
Article Cell Biology

Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells

Mitchell Thorn et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2014)

Article Oncology

Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): Results from a phase I-II clinical trial

Jorge A. Garcia et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)

Letter Immunology

Regulatory T cells: recommendations to simplify the nomenclature

Abul K. Abbas et al.

NATURE IMMUNOLOGY (2013)

Review Oncology

History of myeloid-derived suppressor cells

James E. Talmadge et al.

NATURE REVIEWS CANCER (2013)

Article Immunology

Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking

Ibrahim H. Younos et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2012)

Review Geriatrics & Gerontology

The ageing B cell population: Composition and function

Alexander Ademokun et al.

BIOGERONTOLOGY (2010)

Article Immunology

Changes in circuIating B cells and immunoglobulin cIasses and subcIasses in a healthy aged popuIation

R. PAGANELLI et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)

Article Medicine, General & Internal

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.

Philip W. Kantoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Endocrinology & Metabolism

Immunosuppressive CD14+HLA-DRlow/- Monocytes in Prostate Cancer

Stanimir Vuk-Pavlovic et al.

PROSTATE (2010)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Article Immunology

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells

Moses K. Donkor et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer

William L. Dahut et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2009)

Article Urology & Nephrology

Prostate specific antigen working group guidelines on prostate specific antigen doubling time

Philip M. Arlen et al.

JOURNAL OF UROLOGY (2008)

Article Pharmacology & Pharmacy

Effects of ozone exposure on inactivation of intra- and extracellular enterovirus 71

Ya-Ching Lin et al.

ANTIVIRAL RESEARCH (2006)

Letter Oncology

Serum interleukin-8 is elevated in men with prostate cancer and bone metastases

S Lehrer et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2004)

Review Biochemistry & Molecular Biology

Interleukin-6 and prostate cancer progression

PC Smith et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2001)